Skip to content

B&B PHARMA

Active
Private limited company (pre-2019)founded 20169 yrs activeKruidtuinlaan 5a, 1000 Brussel, BelgiumKBO/BCE: BE 0666.765.726
Summary

The computed 12-month bankruptcy probability of B&B PHARMA is 1.6% (moderate). The 2025 annual accounts show negative equity (-€337,915) and a net result of €2,559. Equity is shrinking by ~8.8% per year across the filed fiscal years. Its solvency ranks better than 5% of 4735 sector peers (fiscal year 2025). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
Axes · tick = 2024
Profitability56▼-44
Solvency0=
Growth58=
Track record100
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.1 against 0.11 in 2024; short-term debt: 945.3% and cash: 7.5% of total assets), and equity is negative.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
-958.8%
Return on assets
7.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 4735 sector peers (2025).
NBB · sector comparison
Position among 4735 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
4 d early
2024
on the day
2023
30 d early
2022
61 d late
2021
36 d late
2020
52 d late
2019
69 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 26 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 48% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 31 July (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

B&B PHARMA was incorporated on 29 November 2016.1 Total assets fell from EUR 203,782 in 2018 to EUR 35,243 in 2025 and headcount from 2.3 full-time equivalents in 2019 to 1 in 2022.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018, 2019, 2022 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
-€337,915▲ 0.8%
2024 · -€340,474
Total assets
€35,243▼ 2.1%
2024 · €35,985
Net result
€2,559▼ 97.8%
2024 · €116,362
Working capital
-€298,415▲ 0.9%
2024 · -€300,974
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 96, Personal service activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€48,236▲ 48.3%€28,548-€84,169€118,171€1,758▼ 98.5%
Net result-€57,786below the sector's middle half▲ 43.5%€22,549above the sector's middle half-€82,710below the sector's middle half€116,362above the sector's middle half€2,559within the sector's middle half▼ 97.8%
Equity-€396,674below the sector's middle half▼ 17.1%-€374,126below the sector's middle half▲ 5.7%-€456,835below the sector's middle half▼ 22.1%-€340,474below the sector's middle half▲ 25.5%-€337,915below the sector's middle half▲ 0.8%
Total assets€346,338above the sector's middle half▼ 13.5%€263,521above the sector's middle half▼ 23.9%€102,325within the sector's middle half▼ 61.2%€35,985within the sector's middle half▼ 64.8%€35,243within the sector's middle half▼ 2.1%
Debt€743,012▲ 0.5%€637,647▼ 14.2%€559,161▼ 12.3%€376,459▼ 32.7%€373,158▼ 0.9%
Working capital-€413,789below the sector's middle half▼ 34.1%-€437,668below the sector's middle half▼ 5.8%-€411,761below the sector's middle half▲ 5.9%-€300,974below the sector's middle half▲ 26.9%-€298,415below the sector's middle half▲ 0.9%
Solvency-114.5%below the sector's middle half▼ 29.9pp-142.0%below the sector's middle half▼ 27.4pp-446.5%below the sector's middle half▼ 304.5pp-946.2%below the sector's middle half▼ 499.7pp-958.8%below the sector's middle half▼ 12.7pp
Current ratio0.30below the sector's middle half▼ 0.110.19below the sector's middle half▼ 0.100.20below the sector's middle half▲ 0.010.11below the sector's middle half▼ 0.090.10below the sector's middle half=
Return on assets (ROA)-16.7%below the sector's middle half▲ 8.8pp8.6%within the sector's middle half▲ 25.2pp-80.8%below the sector's middle half▼ 89.4pp323.4%above the sector's middle half▲ 404.2pp7.3%within the sector's middle half▼ 316.1pp
Staff (FTE)2▼ 50.0%1▼ 50.0%
above within below the middle half (P25 to P75) of NACE 96, Personal service activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€100,000€0€100,000Operating result 2021: -€48,236-€48,236Net result 2021: -€57,786-€57,786Operating result 2022: €28,548€28,548Net result 2022: €22,549€22,549Operating result 2023: -€84,169-€84,169Net result 2023: -€82,710-€82,710Operating result 2024: €118,171€118,171Net result 2024: €116,362€116,362Operating result 2025: €1,758€1,758Net result 2025: €2,559€2,55920212022202320242025-€100,000€0€100,000Operating result 2023: -€84,169-€84,200Net result 2023: -€82,710-€82,700Operating result 2024: €118,171€118,000Net result 2024: €116,362€116,000Operating result 2025: €1,758€1,760Net result 2025: €2,559€2,560202320242025
The operating result falls in 2025; 2025 is 99% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €35,243
Fixed assets €500 =
Current assets €34,743 ▼ 2.1%
Key figures and ratios
2025 value · change against 2024
Debt to equity
-1.10▲
2024 · -1.11
Debt ≤ 1 year
€333,158▼
2024 · €336,459
Debt > 1 year
€40,000=
2024 · €40,000
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 2,180 companies that looked in July 2024 the way this one looks now, 4.8% went bankrupt within 24 months and 89% are still going.

  • Micro
  • 5 to 10 years old
  • negative equity
  • a profit of 5% of the balance sheet or more
4.8% went bankrupt
5.8% stopped otherwise
89% still going

A further 0.5% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.6% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 2,180 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 32 lines
Balance sheet Code20242025
Assets
Total assets20/58€35,985€35,243▼
Fixed assets21/28€500€500=
Financial fixed assets28€500€500=
Current assets29/58€35,485€34,743▼
Amounts receivable within one year40/41€32,030€32,097▲
Other amounts receivable41€32,030€32,097▲
Cash at bank and in hand54/58€3,455€2,646▼
Equity and liabilities
Total equity and liabilities10/49€35,985€35,243▼
Equity10/15-€340,474-€337,915▲
Contributions10/11€18,600€18,600=
Profit (loss) carried forward14-€359,074-€356,515▲
Amounts payable17/49€376,459€373,158▼
Amounts payable after more than one year17€40,000€40,000=
Financial debts170/4€40,000€40,000=
Amounts payable within one year42/48€336,459€333,158▼
Trade debts44€38,983€38,491▼
Suppliers440/4€38,983€38,491▼
Taxes, remuneration and social security45€8,966€124▼
Taxes450/3€8,966€124▼
Other amounts payable47/48€288,511€294,542▲
Income statement Code20242025
Other operating charges640/8€4,669-
Gross operating margin9900€122,840€1,758▼
Operating profit (loss)9901€118,171€1,758▼
Financial income75/76B€1,487€828▼
Recurring financial income75€1,487€828▼
Financial charges65/66B€3,297€27▼
Recurring financial charges65€3,297€27▼
Profit (loss) for the period before taxes9903€116,362€2,559▼
Profit (loss) for the period9904€116,362€2,559▼
Profit (loss) for the period to be appropriated9905€116,362€2,559▼
Appropriation of the result
Profit (loss) to be appropriated9906-€359,074-€356,515▲
Profit (loss) brought forward from the previous period14P-€475,435-€359,074▲

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€45,686€4,716€27,804---
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,827€12,720----
Other operating charges640/8€611€2,341€802€4,669--
Non-recurring operating charges66A--€152,245---
Gross operating margin9900€11,888€48,324€96,682€122,840€1,758▼ 98.6%
Operating profit (loss)9901-€48,236€28,548-€84,169€118,171€1,758▼ 98.5%
Financial income75/76B--€6,685€1,487€828▼ 44.3%
Recurring financial income75--€6,685€1,487€828▼ 44.3%
Financial charges65/66B€9,550€5,999€5,226€3,297€27▼ 99.2%
Recurring financial charges65€9,550€5,999€5,226€3,297€27▼ 99.2%
Profit (loss) for the period before taxes9903-€57,786€22,549-€82,710€116,362€2,559▼ 97.8%
Profit (loss) for the period9904-€57,786€22,549-€82,710€116,362€2,559▼ 97.8%
Profit (loss) for the period to be appropriated9905-€57,786€22,549-€82,710€116,362€2,559▼ 97.8%
Line20212022202320242025Change
Assets
Total assets20/58€346,338€263,521€102,325€35,985€35,243▼ 2.1%
Fixed assets21/28€172,565€159,845€500€500€500=
Tangible fixed assets22/27€172,065€159,345----
Plant, machinery and equipment23€5,890€2,945----
Other tangible fixed assets26€166,175€156,400----
Financial fixed assets28€500€500€500€500€500=
Current assets29/58€173,773€103,676€101,825€35,485€34,743▼ 2.1%
Stocks and contracts in progress3€118,427€67,217----
Stocks30/36€118,427€67,217----
Amounts receivable within one year40/41€40,350€31,641€82,850€32,030€32,097▲ 0.2%
Trade receivables40€3,589€8,610€50,820---
Other amounts receivable41€36,760€23,031€32,030€32,030€32,097▲ 0.2%
Cash at bank and in hand54/58€12,604€4,819€18,975€3,455€2,646▼ 23.4%
Deferred charges and accrued income490/1€2,392-----
Equity and liabilities
Total equity and liabilities10/49€346,338€263,521€102,325€35,985€35,243▼ 2.1%
Equity10/15-€396,674-€374,126-€456,835-€340,474-€337,915▲ 0.8%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Outside capital11€18,600-----
Other1109/19€18,600-----
Profit (loss) carried forward14-€415,274-€392,726-€475,435-€359,074-€356,515▲ 0.7%
Amounts payable17/49€743,012€637,647€559,161€376,459€373,158▼ 0.9%
Amounts payable after more than one year17€155,450€96,302€45,575€40,000€40,000=
Financial debts170/4€155,450€96,302€45,575€40,000€40,000=
Amounts payable within one year42/48€587,562€541,344€513,586€336,459€333,158▼ 1.0%
Current portion of amounts payable after more than one year42€57,802€59,148€50,728---
Financial debts43€50,138€71,138€25,000---
Credit institutions430/8€50,138€71,138€25,000---
Trade debts44€195,098€48,422€34,629€38,983€38,491▼ 1.3%
Suppliers440/4€195,098€48,422€34,629€38,983€38,491▼ 1.3%
Taxes, remuneration and social security45€10,832-€10,816€8,966€124▼ 98.6%
Taxes450/3€10,813-€10,816€8,966€124▼ 98.6%
Remuneration and social security454/9€19-----
Other amounts payable47/48€273,691€362,636€392,414€288,511€294,542▲ 2.1%
Line20212022202320242025Change
Profit (loss) for the period9904-€57,786€22,549-€82,710€116,362€2,559▼ 97.8%
+ Depreciation and write-downs630€13,827€12,720----
Operating cash flow (approximation)-€43,959€35,268-€82,710€116,362€2,559▼ 97.8%
Investment in fixed assets (approximation)-€0€159,345€0€0-
Change in cash--€7,786€14,156-€15,520-€809▲ 94.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Back to profitnet €116,362
Net result €116,362 after one loss-making year.
01-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 61 days late
2022
31-12
Financial Back to profitnet €22,549
Net result €22,549 after 4 loss-making years.
05-09
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 36 days late
2021
21-09
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 52 days late
2020
08-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 69 days late
2019
21-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 21 days late
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2016
seat establishment The establishment unit on the map
Ground area
604 m²
Building footprint
599 m²
Volume, LiDAR
15,120 m³
Parcel 21802B0013/00H000, Brussels · tallest building 32.9 m, ±9 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
B&B PHARMA
Kruidtuinlaan 5a, 1000 BrusselRetail sale of cosmetics and toilet articles
since 20162.259.305.687
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21802B0013/00H000 Brussels 604 m² 1 · 599 m² 32.9 m · 9 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 6,710 companies in sector 96230 we hold annual accounts for 628. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company (pre-2019)
Founded29-11-2016
Fiscal year end31-12
Activities, NACEBEL 2025
96230Day spas, saunas and steam baths
47750Retail sale of cosmetics and toilet articles
E-invoicing
Reachable via Peppol
Peppol ID 0208:0666765726
Also 9925:BE0666765726
Registered 26-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.